Perrigo (PRGO) Profit After Tax (2012 - 2026)
Perrigo's (PRGO) quarterly Profit After Tax came in at -$389.8 million in Q1 2026, down 5990.62% year-on-year from $6.6 million in Q1 2025, and up 72.89% on a QoQ basis from -$1.4 billion in Q4 2025.
Perrigo (PRGO) Profit After Tax (2012 - 2026) Analysis & Trends
Perrigo (PRGO) has 15 years of Profit After Tax data on file, last reported at -$389.8 million in Q1 2026.
- On a quarterly basis, Profit After Tax fell 5990.62% year-over-year to -$389.8 million in Q1 2026; TTM through Mar 2026 was -$1.7 billion, a 886.64% decrease from a year earlier, with the FY2025 full-year figure at -$1.4 billion, down 786.99% from the prior year.
- Profit After Tax for Q1 2026 stood at -$389.8 million, up from -$1.4 billion in the prior quarter.
- Over the last five years, Profit After Tax for PRGO reached as high as $145.4 million in Q2 2025 and fell as low as -$1.4 billion in Q4 2025.
- Historically, Profit After Tax has averaged -$123.5 million across 5 years, with a median of -$21.0 million in 2024.
- Across the five-year window, Profit After Tax surged 234.13% in 2025 and plunged 5990.62% in 2026, its largest moves.
- Year by year, Profit After Tax stood at -$12.7 million in 2022, then plunged by 118.11% to -$27.7 million in 2023, then declined by 20.58% to -$33.4 million in 2024, then plunged by 4204.49% to -$1.4 billion in 2025, then surged by 72.89% to -$389.8 million in 2026.
- Per Business Quant data, the three most recent Profit After Tax figures were -$389.8 million in Q1 2026, -$1.4 billion in Q4 2025, and $12.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 369.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 601.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -2.35 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 274.90 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 176.40 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 197.90 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 57.00 Mn |
| 10 | Perrigo | 1.40 Bn | 1.05 Bn | 325.50 Mn | -389.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | -389.80 Mn |
| Dec 31, 2025 | -1.44 Bn |
| Sep 27, 2025 | 12.70 Mn |
| Jun 28, 2025 | 145.40 Mn |
| Mar 29, 2025 | -6.40 Mn |
| Dec 31, 2024 | -33.40 Mn |
| Sep 28, 2024 | -21.00 Mn |
| Jun 29, 2024 | -108.40 Mn |
| Mar 30, 2024 | -48.40 Mn |
| Dec 31, 2023 | -27.70 Mn |
| Sep 30, 2023 | 15.40 Mn |
| Jul 1, 2023 | 26.20 Mn |
| Apr 1, 2023 | 20.70 Mn |
| Dec 31, 2022 | -12.70 Mn |
| Oct 1, 2022 | -52.10 Mn |
| Jul 2, 2022 | -161.80 Mn |
| Apr 2, 2022 | -20.50 Mn |
| Dec 31, 2021 | 32.10 Mn |
| Oct 2, 2021 | -53.90 Mn |
| Jul 3, 2021 | -57.70 Mn |